
EquitySector - HealthcareVery High Risk
NAV (17-Nov-26)
Returns (Since Inception)
Fund Size
₹44 Cr
Expense Ratio
0.36%
ISIN
INF247L01BB1
Minimum SIP
-
Exit Load
-
Inception Date
29 Jul 2022
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+17.54%
+19.12% (Cat Avg.)
3 Years
+21.64%
+21.25% (Cat Avg.)
Since Inception
+21.74%
— (Cat Avg.)
| Equity | ₹44.46 Cr | 99.91% |
| Others | ₹0.04 Cr | 0.09% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Equity | ₹5.33 Cr | 11.97% |
| Divi's Laboratories Ltd | Equity | ₹3.44 Cr | 7.72% |
| Laurus Labs Ltd | Equity | ₹2.58 Cr | 5.80% |
| Apollo Hospitals Enterprise Ltd | Equity | ₹2.38 Cr | 5.35% |
| Dr Reddy's Laboratories Ltd | Equity | ₹2.28 Cr | 5.13% |
| Cipla Ltd | Equity | ₹2.17 Cr | 4.87% |
| Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹1.77 Cr | 3.97% |
| Torrent Pharmaceuticals Ltd | Equity | ₹1.52 Cr | 3.41% |
| Lupin Ltd | Equity | ₹1.35 Cr | 3.04% |
| Aurobindo Pharma Ltd | Equity | ₹1.29 Cr | 2.89% |
| Fortis Healthcare Ltd | Equity | ₹1.11 Cr | 2.50% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹0.96 Cr | 2.15% |
| Zydus Lifesciences Ltd | Equity | ₹0.86 Cr | 1.93% |
| Alkem Laboratories Ltd | Equity | ₹0.83 Cr | 1.87% |
| Mankind Pharma Ltd | Equity | ₹0.77 Cr | 1.73% |
| Ipca Laboratories Ltd | Equity | ₹0.75 Cr | 1.68% |
| Biocon Ltd | Equity | ₹0.68 Cr | 1.54% |
| Gland Pharma Ltd | Equity | ₹0.68 Cr | 1.53% |
| Sai Life Sciences Ltd | Equity | ₹0.59 Cr | 1.32% |
| Acutaas Chemicals Ltd | Equity | ₹0.57 Cr | 1.29% |
| Krishna Institute of Medical Sciences Ltd | Equity | ₹0.52 Cr | 1.16% |
| Aster DM Quality Care Ltd Ordinary Shares | Equity | ₹0.51 Cr | 1.15% |
| Neuland Laboratories Ltd | Equity | ₹0.47 Cr | 1.06% |
| Ajanta Pharma Ltd | Equity | ₹0.44 Cr | 0.99% |
| Wockhardt Ltd | Equity | ₹0.44 Cr | 0.98% |
| Piramal Pharma Ltd | Equity | ₹0.42 Cr | 0.93% |
| Dr. Lal PathLabs Ltd | Equity | ₹0.41 Cr | 0.92% |
| Abbott India Ltd | Equity | ₹0.36 Cr | 0.82% |
| OneSource Specialty Pharma Ltd | Equity | ₹0.34 Cr | 0.76% |
| Granules India Ltd | Equity | ₹0.33 Cr | 0.75% |
| Narayana Hrudayalaya Ltd | Equity | ₹0.33 Cr | 0.75% |
| Global Health Ltd | Equity | ₹0.31 Cr | 0.70% |
| Shilpa Medicare Ltd | Equity | ₹0.31 Cr | 0.70% |
| Rubicon Research Ltd | Equity | ₹0.3 Cr | 0.66% |
| GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹0.28 Cr | 0.63% |
| Anthem Biosciences Ltd | Equity | ₹0.25 Cr | 0.55% |
| Emcure Pharmaceuticals Ltd | Equity | ₹0.22 Cr | 0.49% |
| Natco Pharma Ltd | Equity | ₹0.21 Cr | 0.48% |
| Syngene International Ltd | Equity | ₹0.21 Cr | 0.48% |
| Jubilant Pharmova Ltd | Equity | ₹0.2 Cr | 0.46% |
| Vijaya Diagnostic Centre Ltd | Equity | ₹0.2 Cr | 0.45% |
| Cohance Lifesciences Ltd | Equity | ₹0.2 Cr | 0.45% |
| Strides Pharma Science Ltd | Equity | ₹0.2 Cr | 0.44% |
| Marksans Pharma Ltd | Equity | ₹0.18 Cr | 0.41% |
| Rainbow Childrens Medicare Ltd | Equity | ₹0.17 Cr | 0.39% |
| Indegene Ltd | Equity | ₹0.17 Cr | 0.38% |
| Eris Lifesciences Ltd Registered Shs | Equity | ₹0.17 Cr | 0.37% |
| Metropolis Healthcare Ltd | Equity | ₹0.16 Cr | 0.36% |
| Pfizer Ltd | Equity | ₹0.15 Cr | 0.35% |
| Poly Medicure Ltd | Equity | ₹0.15 Cr | 0.34% |
| Manipal Health Enterprises Ltd | Equity | ₹0.15 Cr | 0.33% |
| Jupiter Life Line Hospitals Ltd | Equity | ₹0.14 Cr | 0.30% |
| Caplin Point Laboratories Ltd | Equity | ₹0.13 Cr | 0.29% |
| Procter & Gamble Health Ltd | Equity | ₹0.13 Cr | 0.28% |
| Aarti Pharmalabs Ltd | Equity | ₹0.13 Cr | 0.28% |
| Alembic Pharmaceuticals Ltd | Equity | ₹0.12 Cr | 0.27% |
| Alivus Life Sciences Ltd | Equity | ₹0.12 Cr | 0.27% |
| Bliss GVS Pharma Ltd | Equity | ₹0.12 Cr | 0.27% |
| Concord Biotech Ltd | Equity | ₹0.12 Cr | 0.26% |
| Corona Remedies Ltd | Equity | ₹0.11 Cr | 0.25% |
| AstraZeneca Pharma India Ltd | Equity | ₹0.11 Cr | 0.25% |
| Yatharth Hospital and Trauma Care Services Ltd | Equity | ₹0.11 Cr | 0.25% |
| Morepen Laboratories Ltd | Equity | ₹0.11 Cr | 0.24% |
| Dr Agarwal’s Health Care Ltd | Equity | ₹0.11 Cr | 0.24% |
| Viyash Scientific Ltd | Equity | ₹0.1 Cr | 0.21% |
| HealthCare Global Enterprises Ltd | Equity | ₹0.08 Cr | 0.19% |
| Sanofi India Ltd | Equity | ₹0.08 Cr | 0.18% |
| Thyrocare Technologies Ltd | Equity | ₹0.08 Cr | 0.18% |
| Senores Pharmaceuticals Ltd | Equity | ₹0.08 Cr | 0.18% |
| Kovai Medical Center & Hospital Ltd | Equity | ₹0.07 Cr | 0.17% |
| Akums Drugs and Pharmaceuticals Ltd | Equity | ₹0.07 Cr | 0.16% |
| Sanofi Consumer Healthcare India Ltd | Equity | ₹0.06 Cr | 0.14% |
| Nephrocare Health Services Ltd | Equity | ₹0.06 Cr | 0.14% |
| Supriya Lifescience Ltd | Equity | ₹0.06 Cr | 0.14% |
| IOL Chemicals And Pharmaceuticals Ltd | Equity | ₹0.06 Cr | 0.12% |
| Blue Jet Healthcare Ltd | Equity | ₹0.05 Cr | 0.12% |
| Suven Life Sciences Ltd | Equity | ₹0.05 Cr | 0.12% |
| FDC Ltd | Equity | ₹0.05 Cr | 0.11% |
| Ind-Swift Laboratories Ltd | Equity | ₹0.05 Cr | 0.11% |
| Sun Pharma Advanced Research Co Ltd | Equity | ₹0.05 Cr | 0.10% |
| Innova Captab Ltd | Equity | ₹0.05 Cr | 0.10% |
| Park Medi World Ltd | Equity | ₹0.04 Cr | 0.10% |
| Shukra Pharmaceuticals Ltd | Equity | ₹0.04 Cr | 0.10% |
| Kwality Pharmaceuticals Ltd | Equity | ₹0.04 Cr | 0.10% |
| Aarti Drugs Ltd | Equity | ₹0.04 Cr | 0.10% |
| Solara Active Pharma Sciences Ltd Ordinary Shares | Equity | ₹0.04 Cr | 0.10% |
| SMS Pharmaceuticals Ltd | Equity | ₹0.04 Cr | 0.09% |
| Artemis Medicare Services Ltd Ordinary Shares | Equity | ₹0.04 Cr | 0.09% |
| Net Receivables / (Payables) | Cash | ₹0.04 Cr | 0.09% |
| Indraprastha Medical Corp Ltd | Equity | ₹0.04 Cr | 0.08% |
| Orchid Pharma Ltd | Equity | ₹0.04 Cr | 0.08% |
| Advanced Enzyme Technologies Ltd | Equity | ₹0.03 Cr | 0.08% |
| Evonile Pharma Ltd | Equity | ₹0.03 Cr | 0.08% |
| Gujarat Themis Biosyn Ltd | Equity | ₹0.03 Cr | 0.07% |
| Gufic Biosciences Ltd | Equity | ₹0.03 Cr | 0.07% |
| RPG Life Sciences Ltd | Equity | ₹0.03 Cr | 0.07% |
| Unichem Laboratories Ltd | Equity | ₹0.03 Cr | 0.06% |
| Fredun Pharmaceuticals Ltd | Equity | ₹0.03 Cr | 0.06% |
| Venus Remedies Ltd | Equity | ₹0.03 Cr | 0.06% |
| Dishman Carbogen Amics Ltd | Equity | ₹0.03 Cr | 0.06% |
| Krsnaa Diagnostics Ltd | Equity | ₹0.03 Cr | 0.06% |
| Syncom Formulation (India) Ltd | Equity | ₹0.02 Cr | 0.06% |
| Hester Biosciences Ltd | Equity | ₹0.02 Cr | 0.05% |
| Hikal Ltd | Equity | ₹0.02 Cr | 0.05% |
| Indoco Remedies Ltd | Equity | ₹0.02 Cr | 0.05% |
| Amrutanjan Health Care Ltd | Equity | ₹0.02 Cr | 0.05% |
| Vimta Labs Ltd | Equity | ₹0.02 Cr | 0.05% |
| Windlas Biotech Ltd | Equity | ₹0.02 Cr | 0.04% |
| Anlon Healthcare Ltd | Equity | ₹0.02 Cr | 0.04% |
| Dr Agarwal'S Eye Hospital Ltd | Equity | ₹0.02 Cr | 0.04% |
| 3B BlackBio Dx Ltd Shs Demateralised | Equity | ₹0.02 Cr | 0.04% |
| Kopran Ltd | Equity | ₹0.02 Cr | 0.04% |
| Sigachi Industries Ltd | Equity | ₹0.02 Cr | 0.04% |
| Suraksha Diagnostic Ltd | Equity | ₹0.02 Cr | 0.04% |
| Sai Parenteral's Ltd | Equity | ₹0.02 Cr | 0.04% |
| Fischer Medical Ventures Ltd | Equity | ₹0.02 Cr | 0.04% |
| KMC Speciality Hospitals (India) Ltd | Equity | ₹0.02 Cr | 0.04% |
| Panacea Biotec Ltd | Equity | ₹0.01 Cr | 0.03% |
| Lincoln Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.03% |
| Tarsons Products Ltd | Equity | ₹0.01 Cr | 0.03% |
| NGL Fine-Chem Ltd | Equity | ₹0.01 Cr | 0.03% |
| Bajaj Healthcare Ltd | Equity | ₹0.01 Cr | 0.02% |
| Fermenta Biotech Ltd | Equity | ₹0.01 Cr | 0.02% |
| GPT Healthcare Ltd | Equity | ₹0.01 Cr | 0.02% |
| Jagsonpal Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.02% |
| Wanbury Ltd | Equity | ₹0.01 Cr | 0.02% |
| Gujarat Kidney And Super Speciality Ltd | Equity | ₹0.01 Cr | 0.02% |
| Laxmi Dental Ltd | Equity | ₹0.01 Cr | 0.02% |
| Shalby Ltd | Equity | ₹0.01 Cr | 0.02% |
| Themis Medicare Ltd | Equity | ₹0.01 Cr | 0.02% |
| Anuh Pharma Ltd Shs Dematerialised | Equity | ₹0.01 Cr | 0.02% |
| Kilitch Drugs (India) Ltd | Equity | ₹0.01 Cr | 0.01% |
| Gaudium IVF And Women Health Ltd | Equity | ₹0.01 Cr | 0.01% |
| One Global Service Provider Ltd | Equity | ₹0.01 Cr | 0.01% |
| Medicamen Biotech Ltd | Equity | ₹0.01 Cr | 0.01% |
| Ambalal Sarabhai Enterprises Ltd | Equity | ₹0 Cr | 0.01% |
| Fabtech Technologies Ltd | Equity | ₹0 Cr | 0.01% |
| Take Ltd | Equity | ₹0 Cr | 0.01% |
| Gennex Laboratories Ltd | Equity | ₹0 Cr | 0.01% |
| Medico Remedies Ltd Ordinary Shares | Equity | ₹0 Cr | 0.00% |
Large Cap Stocks
33.32%
Mid Cap Stocks
39.12%
Small Cap Stocks
27.14%
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Healthcare | ₹43.85 Cr | 98.55% |
| Basic Materials | ₹0.61 Cr | 1.37% |
Standard Deviation
This fund
16.15%
Cat. avg.
16.11%
Lower the better
Sharpe Ratio
This fund
0.99
Cat. avg.
0.94
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.63
Higher the better
ISIN INF247L01BB1 | Expense Ratio 0.36% | Exit Load - | Fund Size ₹44 Cr | Age 4 years 3 months | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹1,71,341 Cr
Address
Motilal Oswal Tower, Mumbai, 400 025
Your principal amount will be at Very High Risk

Download Dezerv App
Track and monitor all
your investments